Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I Study of Intravenous Triapine® (IND #68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00335998
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:23.619273+00:00
Published At
2013-01-11T00:00:00+00:00
Record Updated At
2013-01-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Recurrent Cervical Cancer", "Recurrent Ovarian Epithelial Cancer", "Recurrent Vaginal Cancer", "Recurrent Vulvar Cancer", "Stage III Vaginal Cancer", "Stage IIIA Cervical Cancer", "Stage IIIA Ovarian Epithelial Cancer", "Stage IIIA Vulvar Cancer", "Stage IIIB Cervical Cancer", "Stage IIIB Ovarian Epithelial Cancer", "Stage IIIB Vulvar Cancer", "Stage IIIC Ovarian Epithelial Cancer", "Stage IIIC Vulvar Cancer", "Stage IV Ovarian Epithelial Cancer", "Stage IVA Cervical Cancer", "Stage IVA Vaginal Cancer", "Stage IVB Cervical Cancer", "Stage IVB Vaginal Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-01-11"
protocolSection.identificationModule.nctId
"NCT00335998"
protocolSection.identificationModule.officialTitle
"Phase I Study of Intravenous Triapine\u00ae (IND #68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies."
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Recurrent Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Recurrent Ovarian Epithelial Cancer (protocolSection.conditionsModule.conditions)
  • Recurrent Vaginal Cancer (protocolSection.conditionsModule.conditions)
  • Recurrent Vulvar Cancer (protocolSection.conditionsModule.conditions)
  • Stage III Vaginal Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Ovarian Epithelial Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIA Vulvar Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIB Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIB Ovarian Epithelial Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIB Vulvar Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIC Ovarian Epithelial Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIIC Vulvar Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Ovarian Epithelial Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVA Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVA Vaginal Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVB Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVB Vaginal Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.